See more : Wataniya Insurance Company (8300.SR) Income Statement Analysis – Financial Results
Complete financial analysis of Reviv3 Procare Company (RVIV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Reviv3 Procare Company, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Molecule Holdings Inc. (EVRRF) Income Statement Analysis – Financial Results
- Transport International Holdings Limited (0062.HK) Income Statement Analysis – Financial Results
- KIOCL Limited (KIOCL.NS) Income Statement Analysis – Financial Results
- Precigen, Inc. (PGEN) Income Statement Analysis – Financial Results
- Visgeneer Inc. (4197.TWO) Income Statement Analysis – Financial Results
Reviv3 Procare Company (RVIV)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.reviveprocare.com
About Reviv3 Procare Company
Reviv3 Procare Company manufactures, markets, distributes, and sells hair and skin care products in the United States, Canada, Europe, and Asia. It offers PREP shampoos; PRIME hair conditioners; TREAT maintenance care products; BOOST to deliver nutrients and enhance circulation to the scalp; MEND deep hair repair masks for added moisture; and PROTECT, a heat protectant product to prevent damage from irons and dryers, as well as thickening sprays for giving hair more volume and body. The company also provides baby care products, such as shampoos, body washes, and lotions under the LANU brand name; and perfumes, mouthwashes, and deodorants, as well as shaving, makeup, and nail products. It serves business-to-business salon through its network of domestic and international distributors; and individuals through its ecommerce site and various third-party online platforms. Reviv3 Procare Company was incorporated in 2015 and is based in El Monte, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 23.52M | 2.34M | 1.63M | 1.01M | 992.67K | 933.22K | 582.01K |
| Cost of Revenue | 5.81M | 828.59K | 599.70K | 480.78K | 553.02K | 576.25K | 281.58K |
| Gross Profit | 17.71M | 1.51M | 1.03M | 531.93K | 439.65K | 356.97K | 300.43K |
| Gross Profit Ratio | 75.30% | 64.53% | 63.29% | 52.53% | 44.29% | 38.25% | 51.62% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.05M | 519.77K | 624.91K | 515.23K | 495.16K | 604.62K | 735.03K |
| Selling & Marketing | 11.68M | 1.20M | 730.06K | 187.82K | 94.13K | 91.20K | 103.60K |
| SG&A | 15.73M | 1.72M | 1.35M | 703.05K | 589.29K | 695.82K | 838.63K |
| Other Expenses | 16.83K | 1.72M | 1.35M | 244.95K | 228.04K | 695.82K | 0.00 |
| Operating Expenses | 15.73M | 1.72M | 1.35M | 703.05K | 589.29K | 695.82K | 838.63K |
| Cost & Expenses | 21.54M | 2.55M | 1.95M | 1.18M | 1.14M | 1.27M | 1.12M |
| Interest Income | 6.47K | 36.00 | 44.00 | 104.00 | 136.00 | 118.00 | 5.00 |
| Interest Expense | 2.52K | 6.54K | 6.08K | 1.75K | 471.00 | 3.81K | 576.00 |
| Depreciation & Amortization | 95.18K | 7.91K | 10.01K | 10.56K | 6.07K | 3.03K | 1.39K |
| EBITDA | 2.10M | -203.50K | -311.04K | -160.56K | -143.57K | -335.70K | -536.82K |
| EBITDA Ratio | 8.94% | -8.71% | -19.04% | -15.85% | -14.46% | -35.97% | -92.24% |
| Operating Income | 1.98M | -211.40K | -321.05K | -171.12K | -149.64K | -338.85K | -538.21K |
| Operating Income Ratio | 8.44% | -9.05% | -19.65% | -16.90% | -15.07% | -36.31% | -92.47% |
| Total Other Income/Expenses | 71.28K | 28.50K | 23.30K | -1.65K | -335.00 | -3.69K | -571.00 |
| Income Before Tax | 2.06M | -182.90K | -297.76K | -172.77K | -149.98K | -342.54K | -538.78K |
| Income Before Tax Ratio | 8.74% | -7.83% | -18.23% | -17.06% | -15.11% | -36.71% | -92.57% |
| Income Tax Expense | 230.91K | -28.50K | 6.08K | 1.75K | 335.00 | 118.00 | 5.00 |
| Net Income | 1.82M | -154.40K | -303.83K | -174.52K | -150.31K | -342.54K | -538.78K |
| Net Income Ratio | 7.76% | -6.61% | -18.60% | -17.23% | -15.14% | -36.71% | -92.57% |
| EPS | 0.02 | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | 0.01 | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| Weighted Avg Shares Out | 379.68M | 41.95M | 41.57M | 41.29M | 40.93M | 40.51M | 40.51M |
| Weighted Avg Shares Out (Dil) | 379.68M | 41.95M | 41.57M | 41.29M | 40.93M | 40.51M | 40.51M |
UPDATE -- REVIV3 Announces Uplist to the NYSE American Exchange and Corporate Name Change to “AXIL Brands, Inc.”
REVIV3 Announces Uplist to the NYSE American Exchange and Corporate Name Change to “AXIL Brands, Inc.”
REVIV3 Procare Company Reports Record Second Quarter Fiscal Year 2024 Financial Results
REVIV3 Procare Company Reports Financial Results for the First Quarter of Fiscal Year 2024
Reviv3 Procare Announces Distribution Agreement with Levelfour Belgique for AXIL Products in Belgium and Luxembourg
REVIV3 Procare Company Reports Record Fiscal Year 2023 Financial Results
7 Best Penny Stocks Under $1 to Buy in July
Reviv3 Procare Company to Present at the 40th Emerging Growth Conference
Reviv3 Procare Reports Record First Quarter 2022 Financial Results
Reviv3 Procare Reports Record First Quarter Financial Results
Source: https://incomestatements.info
Category: Stock Reports